DermTech Inc. (NASDAQ: DMTK) is 56.57% higher on its value in year-to-date trading and has touched a low of $9.64 and a high of $84.49 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DMTK stock was last observed hovering at around $47.01 in the last trading session, with the day’s gains setting it 3.78% off its average median price target of $64.00 for the next 12 months. It is also 35.71% off the consensus price target high of $79.00 offered by 5 analysts, but current levels are -1.58% lower than the price target low of $50.00 for the same period.
Currently trading at $50.79, the stock is -4.71% and -8.64% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing 8.04% at the moment leaves the stock 104.82% off its SMA200. DMTK registered 351.47% gain for a year compared to 6-month gain of 351.87%. The firm has a 50-day simple moving average (SMA 50) of $60.49 and a 200-day simple moving average (SMA200) of $30.58.
The stock witnessed a -25.23% loss in the last 1 month and extending the period to 3 months gives it a 81.33%, and is -1.70% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.65% over the week and 14.81% over the month.
DermTech Inc. (DMTK) has around 118 employees, a market worth around $1.59B and $5.90M in sales. Distance from 52-week low is 426.87% and -39.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-55.30%).
DermTech Inc. (DMTK) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for DermTech Inc. (DMTK) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 1.60, where 0 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
DermTech Inc. quarterly earnings per share for the current quarter are estimated at -$0.43 with sales reaching $2.11M over the same period.The EPS is expected to grow by 26.10% this year, but quarterly earnings will post 107.50% year-over-year. Quarterly sales are estimated to grow 35.50% in year-over-year returns.
DermTech Inc. (DMTK) Top Institutional Holders
125 institutions hold shares in DermTech Inc. (DMTK), with 4.68M shares held by insiders accounting for 16.28% while institutional investors hold 56.57% of the company’s shares. The shares outstanding are 28.76M, and float is at 20.82M with Short Float at 12.09%. Institutions hold 47.36% of the Float.
The top institutional shareholder in the company is RTW Investments LP with over 2.89 million shares valued at $93.66 million. The investor’s holdings represent 10.04% of the DMTK Shares outstanding. As of Dec 30, 2020, the second largest holder is Casdin Capital, LLC with 1.37 million shares valued at $44.44 million to account for 4.76% of the shares outstanding. The other top investors are Federated Hermes, Inc. which holds 1.09 million shares representing 3.80% and valued at over $35.46 million, while Farallon Capital Management LLC holds 2.99% of the shares totaling 0.86 million with a market value of $27.93 million.
DermTech Inc. (DMTK) Insider Activity
The most recent transaction is an insider sale by Wood Todd Michael ,the company’sChief Commercial Officer. SEC filings show that Wood Todd Michael sold 417 shares of the company’s common stock on Mar 08 at a price of $50.04 per share for a total of $20867.0. Following the sale, the insider now owns 0.16 million shares.
DermTech Inc. disclosed in a document filed with the SEC on Mar 08 that Sun Kevin M (Chief Financial Officer) sold a total of 2,886 shares of the company’s common stock. The trade occurred on Mar 08 and was made at $50.04 per share for $0.14 million. Following the transaction, the insider now directly holds 0.15 million shares of the DMTK stock.
Still, SEC filings show that on Mar 08, Ibarra Claudia (Chief Operating Officer) disposed off 2,431 shares at an average price of $50.04 for $0.12 million. The insider now directly holds 114,930 shares of DermTech Inc. (DMTK).